alpha-aminopyridine has been researched along with Ischemic Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, N; Chen, K; Li, M; Li, X; Qin, Y; Wang, H; Xu, B; Xu, J | 1 |
| Cai, N; Li, M; Li, X; Liu, L; Qin, Y; Wang, H; Xu, B; Xu, J | 1 |
2 other study(ies) available for alpha-aminopyridine and Ischemic Stroke
| Article | Year |
|---|---|
Roflumilast, a cyclic nucleotide phosphodiesterase 4 inhibitor, protects against cerebrovascular endothelial injury following cerebral ischemia/reperfusion by activating the Notch1/Hes1 pathway.
Topics: Aminopyridines; Animals; Benzamides; Blood-Brain Barrier; Brain Ischemia; Cerebral Infarction; Cyclopropanes; Endothelial Cells; Humans; Ischemic Stroke; Nucleotides, Cyclic; Phosphodiesterase 4 Inhibitors; Rats; Receptor, Notch1; Reperfusion; Reperfusion Injury; Transcription Factor HES-1 | 2022 |
Roflumilast prevents ischemic stroke-induced neuronal damage by restricting GSK3β-mediated oxidative stress and IRE1α/TRAF2/JNK pathway.
Topics: Aminopyridines; Animals; Apoptosis; Benzamides; Brain Ischemia; Cyclopropanes; Endoribonucleases; Glycogen Synthase Kinase 3 beta; Inositol; Ischemic Stroke; MAP Kinase Signaling System; Neurons; Oxidative Stress; Rats; Reperfusion Injury; Stroke; TNF Receptor-Associated Factor 2 | 2021 |